Literature DB >> 3498521

Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors.

J D Griffin1, A Rambaldi, E Vellenga, D C Young, D Ostapovicz, S A Cannistra.   

Abstract

The interaction of acute myeloblastic leukemia (AML) cells with stromal cells was investigated by adding AML-conditioned media to cultures of human endothelial cells. This conditioned media contained factors that induced expression of both the granulocyte macrophage colony-stimulating factor (GM-CSF) and granulocyte CSF (G-CSF) genes and release of colony stimulating activity from endothelial cells. The conditioned media contained interleukin-1 (IL-1) bioactivity and the endothelial cell stimulatory activity was partially neutralized by anti-IL-1 antiserum. Constitutive expression of the IL-1-beta gene was detected in ten of 17 AML cases analyzed. These results suggest that the unregulated secretion of IL-1 by AML cells can induce stromal cells in vitro to overproduce CSFs. This could contribute to the unrestricted growth of AML cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498521

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

Review 1.  Polypeptides controlling hematopoietic cell development and activation. I. In vitro results.

Authors:  F Herrmann; R Mertelsmann
Journal:  Blut       Date:  1989-03

2.  High interleukin-6 plasma levels in acute promyelocytic leukemia.

Authors:  R Stasi; A Venditti; G del Poeta; M Tribalto; U Coppetelli; G Zaccari; G Papa
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

Review 3.  The role of colony-stimulating factors in acute leukemia.

Authors:  F Herrmann; E Vellenga
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

4.  Cytokine production by a megakaryocytic cell line.

Authors:  B Sandrock; K M Hudson; D E Williams; M A Lieberman
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-04       Impact factor: 2.416

5.  Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control.

Authors:  W Oster; N A Cicco; H Klein; T Hirano; T Kishimoto; A Lindemann; R H Mertelsmann; F Herrmann
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

Review 6.  Normal and leukemic stem cell niches: insights and therapeutic opportunities.

Authors:  Koen Schepers; Timothy B Campbell; Emmanuelle Passegué
Journal:  Cell Stem Cell       Date:  2015-03-05       Impact factor: 24.633

Review 7.  How do normal and leukemic white blood cells egress from the bone marrow? Morphological facts and biochemical riddles.

Authors:  P E Petrides; K H Dittmann
Journal:  Blut       Date:  1990-07

Review 8.  The functional interplay between systemic cancer and the hematopoietic stem cell niche.

Authors:  Amber J Giles; Christopher D Chien; Caitlin M Reid; Terry J Fry; Deric M Park; Rosandra N Kaplan; Mark R Gilbert
Journal:  Pharmacol Ther       Date:  2016-09-02       Impact factor: 12.310

9.  Report of a phase I evaluation of dose and schedule of interleukin-1 alpha and cyclophosphamide in patients with advanced tumors: An Eastern Cooperative Oncology Group study (PX990) and review of IL-1-based studies of hematopoietic reconstitution.

Authors:  Janice P Dutcher; Donna Neuberg; Michael B Atkins; William J Tester; Scott Wadler; James A Stewart; Abraham Chachoua; Lynn M Schuchter
Journal:  J Interferon Cytokine Res       Date:  2014-01-16       Impact factor: 2.607

10.  Inhibition of p38alpha MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment.

Authors:  Tony Navas; Li Zhou; Myka Estes; Edwin Haghnazari; Aaron N Nguyen; Yongkai Mo; Perry Pahanish; Mani Mohindru; Tim Cao; Linda S Higgins; Leonidas C Platanias; Alan List; Amit Verma; T Bhagat; S Gajavelli; S Kambhampati
Journal:  Leuk Lymphoma       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.